CRISPR Therapeutics AG

CRSP-Q

Analysis and Opinions about CRSP-Q

Signal
Opinion
Expert
COMMENT
COMMENT
June 12, 2019
A small company that develops transformative gene medications. They are a small fish in a big sea. A recent transaction with a pharma company allows them to scale out their product, but it is still early. (Analysts’ price target is $58.05)
Show full opinionHide full opinion
A small company that develops transformative gene medications. They are a small fish in a big sea. A recent transaction with a pharma company allows them to scale out their product, but it is still early. (Analysts’ price target is $58.05)
COMMENT
COMMENT
April 25, 2019
They produce a gene-editing tool that splices DNA that has the potential of curing diseases such as Huntington's Chorea and cancer. It's new technology, but he can't think of another company doing this. This segment is very rich and a trading opportunity at best.
Show full opinionHide full opinion
They produce a gene-editing tool that splices DNA that has the potential of curing diseases such as Huntington's Chorea and cancer. It's new technology, but he can't think of another company doing this. This segment is very rich and a trading opportunity at best.
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

CRISPR Therapeutics AG(CRSP-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for CRISPR Therapeutics AG is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

CRISPR Therapeutics AG(CRSP-Q) Frequently Asked Questions

What is CRISPR Therapeutics AG stock symbol?

CRISPR Therapeutics AG is a American stock, trading under the symbol CRSP-Q on the NASDAQ (CRSP). It is usually referred to as NASDAQ:CRSP or CRSP-Q

Is CRISPR Therapeutics AG a buy or a sell?

In the last year, there was no coverage of CRISPR Therapeutics AG published on Stockchase.

Is CRISPR Therapeutics AG a good investment or a top pick?

CRISPR Therapeutics AG was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for CRISPR Therapeutics AG.

Why is CRISPR Therapeutics AG stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is CRISPR Therapeutics AG worth watching?

In the last year, there was no coverage of CRISPR Therapeutics AG published on Stockchase.

What is CRISPR Therapeutics AG stock price?

On 2020-06-04, CRISPR Therapeutics AG (CRSP-Q) stock closed at a price of $63.67.